Snyder Alexandra
Presidente en Merck, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Geoffrey von Maltzahn | M | 43 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 años |
David Tanen | M | 52 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 20 años |
Gevorg Grigoryan | M | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 años |
Molly Gibson | F | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 años |
Joshua Kazam | M | 47 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 20 años |
Noel Laman | M | 84 |
Merck, Inc.
| - |
Avak Kahvejian | M | 48 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 años |
Noubar Afeyan | M | 60 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
Arie Belldegrun | M | 74 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 20 años |
Sean Algeo | M | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Frances Arnold | M | 67 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 5 años |
Stéphane Bancel | M | 51 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
Owen Witte | M | 74 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
James S. Economou | M | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Jane Mendillo | F | 65 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 2 años |
Gary Pisano | M | 62 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
David Chang | M | 64 |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Michael Nohaile | M | 55 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | - |
Michael Nally | M | 48 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 6 años |
Christopher Wilfong | M | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | 19 años |
Grace Larry | M | - |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | 3 años |
Nicole van de Leuv | F | - |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
James McQuade | M | - |
Princeton University
| 5 años |
Martin Leif Peter Fransson | M | 50 |
Princeton University
| 6 años |
Ja-Chin Lee | M | 45 |
Princeton University
| 4 años |
Wade Donald Pfau | M | - |
Princeton University
| 4 años |
Refet Soykan Gürkaynak | M | - |
Princeton University
| 4 años |
Matt Little | M | - |
Princeton University
| 4 años |
Louis Beryl | M | - |
Princeton University
| 4 años |
Gian Felice | M | 51 |
Princeton University
| 5 años |
Eric Tonkyn | M | - |
Princeton University
| 4 años |
Chi Kin Hui | M | 51 |
Princeton University
| 1 años |
Lacaillade Yasmine | F | - |
Princeton University
| 4 años |
Steven Shirreffs | M | - |
Princeton University
| 4 años |
Nate L. Walton | M | 74 |
Princeton University
| 4 años |
Joel Moxley | M | - |
Princeton University
| 4 años |
Ron Gonen | M | - |
Princeton University
| 1 años |
Heather D Lamberton | F | - |
Princeton University
| 4 años |
Ariana Berry | F | - |
Princeton University
| 4 años |
Glenn Rockman | M | 43 |
Princeton University
| 4 años |
Naim Abdullah | M | 41 |
Princeton University
| 4 años |
Damien Bisserier | M | - |
Princeton University
| 4 años |
Thomas William Rowland | M | - |
Princeton University
| 4 años |
Ita Ekpoudom | F | - |
Princeton University
| 4 años |
Michael Ciklin | M | - |
Princeton University
| 4 años |
Juhua Zhu | M | - |
Princeton University
| 3 años |
guneet banga | M | - |
Princeton University
| 4 años |
Graham Sheldon | M | - |
Princeton University
| 4 años |
Andrew James Casino | M | - |
Princeton University
| 4 años |
James Mandel | M | - |
Princeton University
| 4 años |
Elizabeth Addonizio | M | - |
Princeton University
| 2 años |
Lynn Loo | M | - |
Princeton University
| 5 años |
David Alcaly | M | - |
Princeton University
| 4 años |
Miller Girvin | M | - |
Princeton University
| 4 años |
Mark Batsiyan | M | - |
Princeton University
| 4 años |
Allison Ball Swope | F | - |
Princeton University
| 4 años |
Lindsay Rosner | F | - |
Princeton University
| 4 años |
Nate Lowery | M | - |
Princeton University
| 4 años |
Sean Cameron | M | - |
Princeton University
| 4 años |
Serena Dayal | F | - |
Princeton University
| 4 años |
Mark Flickinger | M | - |
Princeton University
| 4 años |
Yeung Kit Lo | M | 45 |
Princeton University
| 4 años |
Liz Rockett | F | - |
Princeton University
| 4 años |
Lexi Fallon | F | - |
Princeton University
| 4 años |
James Yang | M | - |
Princeton University
| 4 años |
John Locke | M | 39 |
Princeton University
| 4 años |
Karen Karniol-Tambour | F | - |
Princeton University
| 4 años |
Tim Ferriss | M | - |
Princeton University
| 5 años |
Mark W. Phanitsiri | M | - |
Princeton University
| 4 años |
Paul Stephen Alexander | M | - |
Princeton University
| 4 años |
Maggie Sahlman | F | - |
Princeton University
| 4 años |
Geoff Gentile | M | - |
Princeton University
| 4 años |
Christine Hunsicker | F | - |
Princeton University
| 4 años |
Sujay Jaswa | M | 44 |
Princeton University
| 4 años |
Alex Nivelle | M | - |
Princeton University
| 4 años |
Alexander G. Liloia | M | - |
Princeton University
| 4 años |
David Shyu | M | - |
Princeton University
| 4 años |
Daniel Riley | M | - |
Princeton University
| 4 años |
Ilya Koffman | M | - |
Princeton University
| 4 años |
Pauline Reader | F | - |
Princeton University
| 4 años |
George J. Azarias | M | - |
Princeton University
| 4 años |
Marin Soljacic | M | - |
Princeton University
| 3 años |
Evgenia Raikh | M | - |
Princeton University
| 4 años |
Nicole Drapkin | F | - |
Princeton University
| 4 años |
Laurence Bleicher | M | - |
Princeton University
| 3 años |
Scott M. Mardy | M | - |
Princeton University
| 4 años |
Conor David Neu | M | - |
Princeton University
| 4 años |
Ruth Lane | F | - |
Princeton University
| 4 años |
Emily johnson lambert | F | - |
Princeton University
| 4 años |
Prashant Rao | M | - |
Princeton University
| 4 años |
Ben Davenport | M | - |
Princeton University
| 9 años |
Andrew Levin | M | 47 |
Princeton University
| 4 años |
Alan Robert Boswell | M | 45 |
Princeton University
| 4 años |
Jack Studer | M | - |
Princeton University
| 4 años |
Brendan Wallace | M | 42 |
Princeton University
| 4 años |
David Rosenthal | M | - |
Princeton University
| 4 años |
John Farris | M | 51 |
Princeton University
| 2 años |
Jared P. Mann | M | - |
Princeton University
| 4 años |
Amy Widdowson | F | - |
Princeton University
| 4 años |
Edward Reynolds | M | - |
Princeton University
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 99 | 99.00% |
Filipinas | 1 | 1.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Snyder Alexandra
- Red Personal